A Revolution in Veterinary Vaccine Production: Shchelkovo Bioplant Increases Production and Develops Exports

The biocomplex continues to develop over 10 new vaccines, some of which are in clinical trials, while others are in the registration process both in RUSSIA and abroad. Particular attention is being paid to developments in pig farming.

The company not only supplies the domestic market but is also actively developing EXPORT markets, supplying vaccines to over 20 countries and continuing registration in six new ones. Over the past five years, vaccine production volumes have increased 3.6-fold thanks to modern technologies and process optimization, allowing for higher product quality.